XShares Announces Availability of Parkinson Disease Foundation's 50th Anniversary Educational Symposium Webcast

NEW YORK, Nov. 13 /PRNewswire/ -- XShares Advisors LLC today announced the availability of a webcast of the Parkinson's Disease Foundation's 50th Anniversary Educational Symposium. The webcast, under editorial control of the Parkinson's Disease Foundation and supported exclusively by XShares, can be found at www.pdf.org/50th/webcast.cfm and offers more than twenty hours of presentations on the most seminal topics in Parkinson's basic and clinical research. XShares commenced a 12-month supporting relationship with the Parkinson's Disease Foundation in July 2007.

XShares offers an innovative means to participate in the biotechnology and life science sector through its HealthShares(TM) family of Exchange-Traded Funds (ETFs). The HealthShares(TM) Neuroscience ETF is comprised of 22 companies that are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of neurological and psychiatric disorders including Parkinson's.

"XShares' relationship with the Parkinson's Disease Foundation allows us to support an outstanding organization while building awareness of the HealthShares(TM) family of ETFs," said Jeff Feldman, Chairman and Founder of XShares Group LLC. "We believe that those who are touched by Parkinson's - whether as donors, educators, advocates or volunteers - will value the opportunity to invest in a portfolio that represents more than 500 neuroscience products and therapies."

"We are pleased to provide public access to the valuable information offered in the symposium's webcast," said Robin Elliott, Parkinson's Disease Foundation's Executive Director. "With the support of XShares, the Parkinson's Disease Foundation is able to reach the global Parkinson's community with essential information on the most important topics in Parkinson's basic and clinical research."

The webcast will be available online for one year. Viewing the webcast is free of charge and can be done so from any computer worldwide with high-speed Internet access.

About XShares Advisors

XShares Advisors LLC, a subsidiary of XShares Group LLC, is a registered investment advisor that provides investment advisory services to Exchange- Traded Funds. XShares also partners with major institutions and index providers seeking to bring innovative Exchange-Traded Funds to market using its administrative platform. In addition, XShares creates and licenses distinctive intellectual property for its ETFs, developing products that allow for innovative trading strategies and alternative investments for the financial community. For more information, visit the website at www.xsharesadvisors.com.

About HealthShares(TM)

HealthShares(TM) is a family of 20 Exchange Traded Funds (ETFs), which are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g., neuroscience, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at www.healthsharesinc.com.

About Parkinson's Disease Foundation

The Parkinson's Disease Foundation (PDF) is a leading national presence in Parkinson's disease research, education and public advocacy. We are working for the nearly one million people in the US living with Parkinson's by funding promising scientific research and supporting people with Parkinson's, their families and caregivers through educational programs and support services. Since its founding in 1957, PDF has funded over $70 million worth of scientific research in Parkinson's disease, supporting the work of leading scientists throughout the world.

An Investor should consider the fund's investment objective, risks, charges and expenses carefully before investing. For this and more complete information about the fund call 800.925.2870 or visit the website www.healthsharesinc.com for a prospectus. Please read the prospectus carefully before investing.

-- There are risks involved with investing in ETFs including possible loss of money. HealthShares(TM) are not actively managed and are subject to risks similar to stocks, including those related to short selling and margin maintenance. Losses from short sales may be unlimited, and losses from purchases on margin may exceed original investment. HealthShares(TM) ETFs are subject to increased risks associated with investing in a specific sector compared to a more diversified investment, as well as unique risks associated with the healthcare and biotechnology sector (i.e., government regulation, patent regulation, etc.).

-- The ETFs face additional risks attributable to their investments in small and medium capitalization companies which are subject to higher volatility than larger, more established companies. In addition, they are invested in a limited number of securities and a decline in the value of these investments would cause the fund's overall value to decline to a greater degree than in a less concentrated portfolio.

-- Global or International Funds invest in foreign securities that will be subject to certain risks not associated with domestic securities, such as currency fluctuations, and changes in political and economic conditions.

The prospectus is not an offer to buy or sell the portfolio shares, nor is the fund soliciting an offer to buy its shares in any jurisdiction where the offer or sale is not permitted.

HealthShares(TM) Exchange Traded Funds are distributed by ALPS Distributors,

                                     Inc.

XShares Advisors LLC and ALPS Distributors, Inc. are unaffiliated entities.

HSI 352 EXP 9-30-2008